This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bionomics Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Tom Reynolds in Therapeutic Formulations
Introduction
Tom Reynolds is an accomplished inventor based in Bend, OR (US). He has made significant contributions to the field of therapeutic formulations, particularly focusing on treatments for central nervous system diseases. His innovative work has the potential to impact the lives of many individuals suffering from anxiety and related disorders.
Latest Patents
Reynolds holds a patent for "Therapeutic formulations and uses thereof." This invention relates to formulations of compound (I) (BNC210), an allosteric modulator of the α7-nicotinic receptor with non-sedative anxiolytic effects. Specifically, it covers solid dispersions, methods of manufacture, and therapeutic methods and uses in treating diseases of the central nervous system.
Career Highlights
Tom Reynolds is currently associated with Bionomics Inc., where he continues to develop innovative solutions in the pharmaceutical sector. His work is characterized by a commitment to advancing therapeutic options for patients in need.
Collaborations
Reynolds collaborates with talented professionals such as Dharam Paul and Julia Crossman, contributing to a dynamic and innovative work environment.
Conclusion
Tom Reynolds exemplifies the spirit of innovation in the field of therapeutic formulations, with his work promising to enhance treatment options for central nervous system disorders. His contributions are noteworthy and reflect a dedication to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile